5 Leading Growth Stocks to Buy in 2021 and Beyond
These industry pioneers can be long-term contributors to a growth portfolio.
Mindfully Curated
These industry pioneers can be long-term contributors to a growth portfolio.
Zoom is an enduring growth story. Sure, it’s “expensive,” but it’s worth paying up for.
Reopening trade aside, e-commerce has a long runway for growth.
Resilient companies are always worth a closer look.
Pfizer’s abrocitinib faces some challenges despite encouraging late-stage results for the drug in treating eczema.
The chipmaker faces a long and painful turnaround.
With yields ranging from 1.8% to 9%, these income stocks will pad seniors’ pockets and allow them to sleep easy at night.
You can go big this month with these three pharmaceutical stocks.
There’s a one-word answer: delta.
If you haven’t considered a Roth IRA before, now is a great time to do so.
This latecomer may come out ahead in one particular area in the long run.
The arguments for these two stocks are compelling.
The likelihood of a market pullback appears to be growing. For long-term investors looking to put their cash to work, that’s a good thing.
Social Security may have to reduce benefits in the future, but there’s no sense in losing sleep over that possibility.
The market has forgotten about these entertainment powerhouses.
A private equity firm and several peers are cashing out of a pile of shares.
An antitrust ruling has investors concerned.
For investors, the company’s price for a new share issue isn’t right.
If you’re planning to collect Social Security at age 70 this year, then this is the most you can collect in monthly benefits.
Just when it looks like China’s regulators are done imposing new restrictions, they tack on one more.